Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Nitrosamine Fallout: EMA Pushes For Stricter Active Substance Manufacturing Controls
Feb 12 2026
•
By
Vibha Sharma
Stricter controls on active substance manufacturing can safeguard medicine quality
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance